nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylate-sodium—Arrhythmia—Fludarabine—lymphatic system cancer	0.00409	0.00409	CcSEcCtD
Salicylate-sodium—Burning sensation—Methotrexate—lymphatic system cancer	0.00389	0.00389	CcSEcCtD
Salicylate-sodium—Chest pain—Teniposide—lymphatic system cancer	0.00386	0.00386	CcSEcCtD
Salicylate-sodium—Hypokalaemia—Carmustine—lymphatic system cancer	0.00386	0.00386	CcSEcCtD
Salicylate-sodium—Cyanosis—Methotrexate—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Salicylate-sodium—Dehydration—Vincristine—lymphatic system cancer	0.00376	0.00376	CcSEcCtD
Salicylate-sodium—Confusional state—Teniposide—lymphatic system cancer	0.00373	0.00373	CcSEcCtD
Salicylate-sodium—Oedema—Teniposide—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Salicylate-sodium—Blood creatinine increased—Mitoxantrone—lymphatic system cancer	0.00369	0.00369	CcSEcCtD
Salicylate-sodium—Acute coronary syndrome—Bleomycin—lymphatic system cancer	0.00369	0.00369	CcSEcCtD
Salicylate-sodium—Infection—Teniposide—lymphatic system cancer	0.00368	0.00368	CcSEcCtD
Salicylate-sodium—Myocardial infarction—Bleomycin—lymphatic system cancer	0.00367	0.00367	CcSEcCtD
Salicylate-sodium—Dehydration—Mitoxantrone—lymphatic system cancer	0.00366	0.00366	CcSEcCtD
Salicylate-sodium—Dysphagia—Carmustine—lymphatic system cancer	0.00366	0.00366	CcSEcCtD
Salicylate-sodium—Tachycardia—Teniposide—lymphatic system cancer	0.00361	0.00361	CcSEcCtD
Salicylate-sodium—Abdominal pain upper—Mitoxantrone—lymphatic system cancer	0.0036	0.0036	CcSEcCtD
Salicylate-sodium—Hypokalaemia—Mitoxantrone—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00358	0.00358	CcSEcCtD
Salicylate-sodium—Pruritus—Mechlorethamine—lymphatic system cancer	0.00355	0.00355	CcSEcCtD
Salicylate-sodium—Anorexia—Teniposide—lymphatic system cancer	0.00353	0.00353	CcSEcCtD
Salicylate-sodium—Hypotension—Teniposide—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Salicylate-sodium—Convulsion—Fludarabine—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Salicylate-sodium—Necrosis—Methotrexate—lymphatic system cancer	0.00345	0.00345	CcSEcCtD
Salicylate-sodium—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00344	0.00344	CcSEcCtD
Salicylate-sodium—Abscess—Methotrexate—lymphatic system cancer	0.00342	0.00342	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.00334	0.00334	CcSEcCtD
Salicylate-sodium—Sweating increased—Mitoxantrone—lymphatic system cancer	0.00332	0.00332	CcSEcCtD
Salicylate-sodium—Dyspnoea—Teniposide—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Salicylate-sodium—Confusional state—Fludarabine—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Salicylate-sodium—Oedema—Fludarabine—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Salicylate-sodium—Infection—Fludarabine—lymphatic system cancer	0.00323	0.00323	CcSEcCtD
Salicylate-sodium—Decreased appetite—Teniposide—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Salicylate-sodium—Renal failure—Carmustine—lymphatic system cancer	0.00321	0.00321	CcSEcCtD
Salicylate-sodium—Vomiting—Mechlorethamine—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Salicylate-sodium—Rash—Mechlorethamine—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
Salicylate-sodium—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00315	0.00315	CcSEcCtD
Salicylate-sodium—Anorexia—Fludarabine—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Salicylate-sodium—Extravasation—Methotrexate—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Salicylate-sodium—Weight increased—Mitoxantrone—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Salicylate-sodium—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.00307	0.00307	CcSEcCtD
Salicylate-sodium—Myocardial infarction—Vincristine—lymphatic system cancer	0.00306	0.00306	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Teniposide—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Salicylate-sodium—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Salicylate-sodium—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Salicylate-sodium—Renal failure—Mitoxantrone—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Salicylate-sodium—Nausea—Mechlorethamine—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Salicylate-sodium—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Salicylate-sodium—Urticaria—Teniposide—lymphatic system cancer	0.00294	0.00294	CcSEcCtD
Salicylate-sodium—Oliguria—Methotrexate—lymphatic system cancer	0.00293	0.00293	CcSEcCtD
Salicylate-sodium—Abdominal pain—Teniposide—lymphatic system cancer	0.00293	0.00293	CcSEcCtD
Salicylate-sodium—Body temperature increased—Teniposide—lymphatic system cancer	0.00293	0.00293	CcSEcCtD
Salicylate-sodium—Erythema—Bleomycin—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Salicylate-sodium—Paraesthesia—Fludarabine—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Salicylate-sodium—Hallucination—Carmustine—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Salicylate-sodium—Dyspnoea—Fludarabine—lymphatic system cancer	0.0029	0.0029	CcSEcCtD
Salicylate-sodium—Dyspepsia—Fludarabine—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Salicylate-sodium—Ulcer—Methotrexate—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Salicylate-sodium—Decreased appetite—Fludarabine—lymphatic system cancer	0.00283	0.00283	CcSEcCtD
Salicylate-sodium—Fatigue—Fludarabine—lymphatic system cancer	0.00281	0.00281	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Salicylate-sodium—Hallucination—Vincristine—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Salicylate-sodium—Pain—Fludarabine—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Salicylate-sodium—Constipation—Fludarabine—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Teniposide—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Salicylate-sodium—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Salicylate-sodium—Asthenia—Teniposide—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Salicylate-sodium—Pruritus—Teniposide—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Salicylate-sodium—Arrhythmia—Carmustine—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Salicylate-sodium—Skin exfoliation—Methotrexate—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Salicylate-sodium—Body temperature increased—Fludarabine—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Salicylate-sodium—Erythema—Carmustine—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Salicylate-sodium—Diarrhoea—Teniposide—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Salicylate-sodium—Chest pain—Bleomycin—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Salicylate-sodium—Ecchymosis—Methotrexate—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Salicylate-sodium—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Salicylate-sodium—Confusional state—Bleomycin—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Salicylate-sodium—Vision blurred—Carmustine—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Fludarabine—lymphatic system cancer	0.0024	0.0024	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Salicylate-sodium—Oedema—Bleomycin—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Salicylate-sodium—Erythema—Mitoxantrone—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Salicylate-sodium—Infection—Bleomycin—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Salicylate-sodium—Vomiting—Teniposide—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Salicylate-sodium—Sepsis—Methotrexate—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Salicylate-sodium—Asthenia—Fludarabine—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Salicylate-sodium—Rash—Teniposide—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Salicylate-sodium—Dermatitis—Teniposide—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Salicylate-sodium—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Salicylate-sodium—Headache—Teniposide—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Salicylate-sodium—Pruritus—Fludarabine—lymphatic system cancer	0.0023	0.0023	CcSEcCtD
Salicylate-sodium—Anorexia—Bleomycin—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Salicylate-sodium—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Salicylate-sodium—Hypotension—Bleomycin—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Salicylate-sodium—Diarrhoea—Fludarabine—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Salicylate-sodium—Convulsion—Carmustine—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Salicylate-sodium—Nausea—Teniposide—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Salicylate-sodium—Chest pain—Carmustine—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Salicylate-sodium—Anxiety—Carmustine—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Salicylate-sodium—Paraesthesia—Bleomycin—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Salicylate-sodium—Dyspnoea—Bleomycin—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Salicylate-sodium—Renal failure acute—Methotrexate—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Salicylate-sodium—Convulsion—Vincristine—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Salicylate-sodium—Confusional state—Carmustine—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Salicylate-sodium—Oedema—Carmustine—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Salicylate-sodium—Decreased appetite—Bleomycin—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Salicylate-sodium—Infection—Carmustine—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Salicylate-sodium—Vomiting—Fludarabine—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Salicylate-sodium—Convulsion—Mitoxantrone—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Salicylate-sodium—Rash—Fludarabine—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Salicylate-sodium—Dermatitis—Fludarabine—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Salicylate-sodium—Pain—Bleomycin—lymphatic system cancer	0.00204	0.00204	CcSEcCtD
Salicylate-sodium—Headache—Fludarabine—lymphatic system cancer	0.00204	0.00204	CcSEcCtD
Salicylate-sodium—Tachycardia—Carmustine—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Salicylate-sodium—Chest pain—Mitoxantrone—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Salicylate-sodium—Anxiety—Mitoxantrone—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Salicylate-sodium—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.002	0.002	CcSEcCtD
Salicylate-sodium—Lethargy—Methotrexate—lymphatic system cancer	0.002	0.002	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Salicylate-sodium—Oedema—Vincristine—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Salicylate-sodium—Anorexia—Carmustine—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Salicylate-sodium—Infection—Vincristine—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Salicylate-sodium—Confusional state—Mitoxantrone—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Salicylate-sodium—Hypotension—Carmustine—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Salicylate-sodium—Oedema—Mitoxantrone—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Salicylate-sodium—Nausea—Fludarabine—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Salicylate-sodium—Infection—Mitoxantrone—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Salicylate-sodium—Shock—Mitoxantrone—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Salicylate-sodium—Urticaria—Bleomycin—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Salicylate-sodium—Anorexia—Vincristine—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Salicylate-sodium—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Salicylate-sodium—Body temperature increased—Bleomycin—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Salicylate-sodium—Irritability—Methotrexate—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Salicylate-sodium—Paraesthesia—Carmustine—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Salicylate-sodium—Hypotension—Vincristine—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Salicylate-sodium—Dyspnoea—Carmustine—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Salicylate-sodium—Somnolence—Carmustine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Salicylate-sodium—Anorexia—Mitoxantrone—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Salicylate-sodium—Decreased appetite—Carmustine—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Salicylate-sodium—Hypotension—Mitoxantrone—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Salicylate-sodium—Paraesthesia—Vincristine—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Salicylate-sodium—Constipation—Carmustine—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Salicylate-sodium—Pain—Carmustine—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Salicylate-sodium—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Salicylate-sodium—Decreased appetite—Vincristine—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Salicylate-sodium—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Salicylate-sodium—Somnolence—Mitoxantrone—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Carmustine—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Salicylate-sodium—Fatigue—Vincristine—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Salicylate-sodium—Asthenia—Bleomycin—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Salicylate-sodium—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Salicylate-sodium—Pain—Vincristine—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Salicylate-sodium—Constipation—Vincristine—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Salicylate-sodium—Asthma—Methotrexate—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Salicylate-sodium—Pruritus—Bleomycin—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Salicylate-sodium—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Salicylate-sodium—Fatigue—Mitoxantrone—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Salicylate-sodium—Constipation—Mitoxantrone—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Salicylate-sodium—Pain—Mitoxantrone—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Salicylate-sodium—Body temperature increased—Carmustine—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Salicylate-sodium—Abdominal pain—Carmustine—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Salicylate-sodium—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Salicylate-sodium—Abdominal pain—Vincristine—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Salicylate-sodium—Body temperature increased—Vincristine—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Salicylate-sodium—Urticaria—Mitoxantrone—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Carmustine—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Salicylate-sodium—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Salicylate-sodium—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Salicylate-sodium—Vomiting—Bleomycin—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Salicylate-sodium—Drowsiness—Methotrexate—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Salicylate-sodium—Rash—Bleomycin—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Salicylate-sodium—Dermatitis—Bleomycin—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Salicylate-sodium—Asthenia—Carmustine—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Salicylate-sodium—Renal failure—Methotrexate—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Vincristine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Salicylate-sodium—Epistaxis—Methotrexate—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Salicylate-sodium—Asthenia—Vincristine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Salicylate-sodium—Diarrhoea—Carmustine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Salicylate-sodium—Nausea—Bleomycin—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Salicylate-sodium—Asthenia—Mitoxantrone—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Salicylate-sodium—Dizziness—Carmustine—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Salicylate-sodium—Diarrhoea—Vincristine—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Salicylate-sodium—Hepatitis—Methotrexate—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Salicylate-sodium—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Salicylate-sodium—Vomiting—Carmustine—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Salicylate-sodium—Dizziness—Vincristine—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Salicylate-sodium—Rash—Carmustine—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Salicylate-sodium—Dermatitis—Carmustine—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Salicylate-sodium—Headache—Carmustine—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Salicylate-sodium—Tinnitus—Methotrexate—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Salicylate-sodium—Vomiting—Vincristine—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Salicylate-sodium—Rash—Vincristine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Salicylate-sodium—Dermatitis—Vincristine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Salicylate-sodium—Headache—Vincristine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Salicylate-sodium—Nausea—Carmustine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Salicylate-sodium—Vomiting—Mitoxantrone—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Salicylate-sodium—Rash—Mitoxantrone—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Salicylate-sodium—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Salicylate-sodium—Headache—Mitoxantrone—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Salicylate-sodium—Erythema—Methotrexate—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Salicylate-sodium—Nausea—Vincristine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Salicylate-sodium—Dysgeusia—Methotrexate—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Salicylate-sodium—Nausea—Mitoxantrone—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Salicylate-sodium—Vision blurred—Methotrexate—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Salicylate-sodium—Convulsion—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Salicylate-sodium—Chest pain—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Salicylate-sodium—Confusional state—Methotrexate—lymphatic system cancer	0.000973	0.000973	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000965	0.000965	CcSEcCtD
Salicylate-sodium—Infection—Methotrexate—lymphatic system cancer	0.000959	0.000959	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000933	0.000933	CcSEcCtD
Salicylate-sodium—Anorexia—Methotrexate—lymphatic system cancer	0.00092	0.00092	CcSEcCtD
Salicylate-sodium—Hypotension—Methotrexate—lymphatic system cancer	0.000902	0.000902	CcSEcCtD
Salicylate-sodium—Paraesthesia—Methotrexate—lymphatic system cancer	0.000866	0.000866	CcSEcCtD
Salicylate-sodium—Dyspnoea—Methotrexate—lymphatic system cancer	0.00086	0.00086	CcSEcCtD
Salicylate-sodium—Somnolence—Methotrexate—lymphatic system cancer	0.000858	0.000858	CcSEcCtD
Salicylate-sodium—Dyspepsia—Methotrexate—lymphatic system cancer	0.000849	0.000849	CcSEcCtD
Salicylate-sodium—Decreased appetite—Methotrexate—lymphatic system cancer	0.000839	0.000839	CcSEcCtD
Salicylate-sodium—Fatigue—Methotrexate—lymphatic system cancer	0.000832	0.000832	CcSEcCtD
Salicylate-sodium—Pain—Methotrexate—lymphatic system cancer	0.000825	0.000825	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000795	0.000795	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000789	0.000789	CcSEcCtD
Salicylate-sodium—Urticaria—Methotrexate—lymphatic system cancer	0.000767	0.000767	CcSEcCtD
Salicylate-sodium—Body temperature increased—Methotrexate—lymphatic system cancer	0.000763	0.000763	CcSEcCtD
Salicylate-sodium—Abdominal pain—Methotrexate—lymphatic system cancer	0.000763	0.000763	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000711	0.000711	CcSEcCtD
Salicylate-sodium—Asthenia—Methotrexate—lymphatic system cancer	0.000692	0.000692	CcSEcCtD
Salicylate-sodium—Pruritus—Methotrexate—lymphatic system cancer	0.000683	0.000683	CcSEcCtD
Salicylate-sodium—Diarrhoea—Methotrexate—lymphatic system cancer	0.00066	0.00066	CcSEcCtD
Salicylate-sodium—Dizziness—Methotrexate—lymphatic system cancer	0.000638	0.000638	CcSEcCtD
Salicylate-sodium—Vomiting—Methotrexate—lymphatic system cancer	0.000613	0.000613	CcSEcCtD
Salicylate-sodium—Rash—Methotrexate—lymphatic system cancer	0.000608	0.000608	CcSEcCtD
Salicylate-sodium—Dermatitis—Methotrexate—lymphatic system cancer	0.000608	0.000608	CcSEcCtD
Salicylate-sodium—Headache—Methotrexate—lymphatic system cancer	0.000604	0.000604	CcSEcCtD
Salicylate-sodium—Nausea—Methotrexate—lymphatic system cancer	0.000573	0.000573	CcSEcCtD
